Skip to main content
. 2010 Sep 2;2010:917356. doi: 10.1155/2010/917356

Figure 1.

Figure 1

(a) Cancer-specific survival for overall patients with combined hepatocellular and cholangiocarcinoma of the liver (cHCC-CC). (b) Cancer-specific survival rate of patients according to SEER stage. P < .0001 for Localized versus Regional versus Distant stage. (c) Cancer-specific survival rate of patients with localized disease according to treatment. P < .0001 for transplantation versus resection versus other surgery* versus no surgery. (d) Cancer-specific survival rate of patients according to year of diagnosis. *Other surgery: local surgery plus unknown surgery.